Nathalie Issaly Selected Research

CAC protocol

1/2010

Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathalie Issaly Research Topics

Disease

3	Neoplasms (Cancer) 01/2012 - 01/2010
2	Carcinogenesis 01/2012 - 01/2012
1	Retinoblastoma (Glioblastoma, Retinal) 01/2012
1	Inflammation (Inflammations) 01/2010
1	Colitis-Associated Neoplasms 01/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2010
1	Colitis 01/2010

Drug/Important Bio-Agent (IBA)

2	triflorcasIBA 01/2012 - 01/2012
1	benzothiazoleIBA 01/2012
1	NucleophosminIBA 01/2012
1	AmidesIBA 01/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	Proto-Oncogene Proteins c-metIBA 01/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2010
1	AzoxymethaneIBA 01/2010
1	Dextrans (Dextran)FDA Link 01/2010
1	NF-kappa B (NF-kB)IBA 01/2010

Therapy/Procedure

2	Therapeutics 01/2012 - 01/2010
1	Molecular Targeted Therapy 01/2012
1	CAC protocol 01/2010